The Star Rating's Blind Spot: What's Really Happening with Medications in Nursing Homes
The federal government tracks drug over-reliance, but the public rating system only counts one piece of the puzzle.
Get Palmelle in your Google results.
One tap. Google shows our reporting higher when you search.
In late 2023, a Centers for Medicare & Medicaid Services (CMS) report detailed a startling trend: over a quarter of nursing homes were flagged for potentially inappropriate antipsychotic prescriptions for residents with dementia. This wasn't an abstract statistic; it was a snapshot of real people in real facilities, potentially receiving drugs that could increase their risk of serious side effects. The report specifically highlighted that these prescriptions were often given without a clear diagnosis or a documented plan to reduce them, a critical point for anyone trying to assess a facility's actual care practices. [c1] I saw that report while trying to figure out the medication list for my mother's new care plan. She’s been experiencing some cognitive decline, and the idea of her being prescribed something without a clear benefit, or worse, with significant risks, felt like a punch to the gut. It made me wonder how often this happens and, more importantly, how someone is supposed to know. My complaint with how this whole situation gets framed is that the focus often lands on the 'star rating' as if it's the final word on a facility's quality. It’s treated like a Michelin star for food, implying perfection. But the reality is that these ratings can be misleading, especially when it comes to the very specific, very important issue of medication management. The public gets one number, and it doesn't tell the whole story. The standard industry defense, if you push on this, is that CMS does have oversight. They point to initiatives like the National Partnership to Improve Dementia Care, which aims to reduce antipsychotic use. They'll say that facilities are audited and that the star ratings do incorporate some quality measures related to medication. But here’s the kill shot: that star rating system, the one everyone sees, only factors in *one* of the four key federal drug classes that CMS monitors for potential overuse. It ignores three other categories of drugs that are also frequently overprescribed and carry significant risks. It’s like grading a restaurant on its appetizer menu while ignoring the main course and dessert. The concrete, underreported move you can make this week is to ask specifically about the facility's policies and practices regarding *all four* federal drug categories. Don't just ask about antipsychotics. Ask about the others too, and how they track and aim to reduce their use. Get the facility's written policy on it.
The direct answer
The federal government tracks the overuse of four specific drug classes in nursing homes, but the widely publicized CMS star rating system only includes data on one of these classes. This means a facility could appear to be doing well in its star rating while still having significant issues with other potentially overused medications.
The Four Drug Classes CMS Watches
CMS, through its Quality Improvement Organizations, keeps a close eye on the inappropriate use of several drug categories in nursing homes. These aren't just random medications; they are drugs that carry significant risks, especially for older adults with complex health needs. The primary categories of concern are:
1. Antipsychotics: These are a major focus, particularly for residents with dementia, where their use is often questioned. The goal is to reduce their use when not medically necessary.
2. Anti-anxiety drugs (Anxiolytics) and Sedatives/Hypnotics: These are often prescribed for sleep or agitation. However, they can lead to falls, confusion, and dependency, and their long-term use is frequently discouraged.
3. Antibiotics: While essential for treating infections, there’s concern about overuse, which can lead to antibiotic resistance – a growing public health crisis.
4. Opioid Pain Relievers: Their use is monitored to prevent misuse and ensure appropriate pain management without leading to addiction or excessive sedation.
Each of these drug classes requires careful consideration and a documented plan for reduction or discontinuation when appropriate. The aim is to ensure residents receive necessary medications for their conditions, but not to rely on drugs as a default for managing behavior or symptoms that could be addressed through other means.
How the Star Rating System Falls Short
The federal CMS star rating system, while providing a valuable overview, simplifies a complex picture. The overall rating for a care facility is derived from three components: health inspections, staffing levels, and quality measures. The crucial point here is that the 'quality measures' component, which includes drug-related data, currently only incorporates data on antipsychotic drug use for long-stay residents. [c2]
This means that while a facility might be doing an excellent job of monitoring and reducing antipsychotic prescriptions, it could still be over-relying on sedatives, antibiotics, or opioids. The public-facing star rating wouldn't necessarily reflect these other issues. For families looking at these ratings, it creates a blind spot. They might see a four-star facility and assume it excels in all aspects of medication management, when in reality, the rating only reflects a fraction of the picture.
This selective reporting can lead to a false sense of security. A facility might be diligent about antipsychotic reduction to boost its star rating, while continuing to use other classes of drugs more liberally, without the same public scrutiny. It’s a well-intentioned system that, by necessity of summarization, misses critical details about the day-to-day pharmaceutical practices within a facility.
Want more of this?
Mark Palmelle a preferred source and it shows up when you search Google.
What to Ask Beyond the Star Rating
When evaluating a care facility, it’s imperative to go beyond the readily available star rating. Ask direct questions about their medication management protocols for all four drug classes CMS monitors. Inquire about their policies on reducing the use of anti-anxiety drugs, sedatives, and opioids. Request to see their documentation on antibiotic stewardship, which details how they prevent unnecessary prescriptions and combat resistance.
Understand their process for medication reviews. Do they conduct regular reviews by a pharmacist or a physician? Are these reviews focused on appropriateness, potential interactions, and opportunities for dose reduction? A facility that can clearly articulate its multi-drug class monitoring and reduction strategies is likely more attentive to comprehensive resident care. [c3]
Look for evidence of a person-centered approach. Are behavioral symptoms addressed through non-pharmacological interventions first? This might include environmental adjustments, increased activities, or different communication strategies. A facility that prioritizes these methods before resorting to medication demonstrates a deeper understanding of resident needs and a commitment to minimizing drug reliance.
Common mistakes
- Relying solely on the CMS Star Rating for medication quality.
The star rating is a useful starting point, but it only accounts for one of the four key drug classes CMS monitors. Overlooking the other three can lead to choosing a facility that has significant issues with other potentially overused and risky medications. - Not asking specific questions about medication reduction plans.
Facilities may have general policies, but it's crucial to understand their active strategies for reducing reliance on anxiolytics, sedatives, antibiotics, and opioids, not just antipsychotics. Inquire about pharmacist consultations and non-drug interventions.
Frequently asked
Which four drug classes does CMS monitor for overuse in nursing homes?
CMS monitors antipsychotics, anti-anxiety drugs (anxiolytics), sedatives/hypnotics, antibiotics, and opioid pain relievers. The star rating system currently only incorporates data on antipsychotic drug use for long-stay residents. [c2]
How can I find out if a facility is overusing other medications besides antipsychotics?
You need to ask specific questions during your facility tours and review process. Inquire about their policies and practices for monitoring and reducing the use of anxiolytics, sedatives, antibiotics, and opioids. Ask about their antibiotic stewardship program and their approach to non-pharmacological interventions for behavioral symptoms.
What is antibiotic stewardship in a care facility?
Antibiotic stewardship is a set of coordinated actions intended to improve the appropriate use of antimicrobial medications. In a care facility, this means ensuring antibiotics are prescribed only when truly necessary, for the correct duration and at the correct dose, to prevent resistance and minimize side effects. [c3]
Sources
- CMS National Partnership to Improve Dementia Care Progress Report 2023 — Details on antipsychotic use trends and facility-level data.
- Medicare.gov About the Star Ratings — Explains the components of the star rating system, including quality measures.
- CDC Antibiotic Stewardship — Provides information on the importance of antibiotic stewardship programs and their implementation.
More from Inside the Industry → · Back to Perch · Browse all stories
More of this, in your Google results.
Takes one tap, and it applies everywhere you search — not just this page.